Cryopreservation failure during ATMP manufacturing: patient safety impact and disposition



Published on 30/12/2025

Further reading: Advanced Therapy Medicinal Products (ATMPs)

Coping with Cryopreservation Failures in ATMP Manufacturing: An In-Depth Investigative Guide

Cryopreservation is a critical process in the manufacturing of Advanced Therapy Medicinal Products (ATMPs). Failures during this stage can lead to significant patient safety concerns and regulatory challenges. This article will provide pharmaceutical professionals with a structured approach for investigating cryopreservation failures, outlining practical steps to identify root causes, implement corrective actions, and ensure compliance with regulatory standards.

By examining real-world scenarios, you will learn how to effectively assess symptoms, categorize potential causes, and develop a comprehensive corrective and preventive action (CAPA) strategy to mitigate risks associated with cryopreservation failures in ATMP manufacturing.

Symptoms/Signals on the Floor or in the Lab

Identifying the symptoms or signals of a cryopreservation failure is the first step in investigation. Common indicators include:

  • Increased incidence of out-of-specification (OOS) results for cell viability post-thaw.
  • Anomalies in temperature readings and deviations from established storage protocols.
  • Unexpected changes in cell morphology or functionality after thawing.
  • Batch failure reports or complaints relating to product
quality from the quality control (QC) department.

Each of these signals must be documented thoroughly as they provide critical clues regarding the nature and extent of the problem. Additionally, performing a preliminary assessment of recent production logs and environmental data can assist in identifying potential patterns or trends related to the observed symptoms.

Likely Causes

The potential causes of cryopreservation failure can be categorized into six key areas: Materials, Method, Machine, Man (Personnel), Measurement, and Environment. Understanding these categories can help streamline the investigation process.

1. Materials

Variability in the quality of biological materials (e.g., cells, media) used in the manufacturing process can lead to inconsistencies in the freezing and thawing processes. Factors such as the source, age, and handling history of the materials may directly impact their viability throughout the procedure.

2. Method

Deficiencies in the cryopreservation method itself, including thawing protocols or freezing rates, can significantly affect the outcome. Inadequate optimization for specific cell types may result in reduced post-thaw recovery.

3. Machine

Equipment malfunctions or calibration issues with freezers or liquid nitrogen tanks may compromise temperature integrity. Regular maintenance and operational checks are essential to ensure compliance with established specifications.

4. Man (Personnel)

Lack of training or adherence to procedures among personnel operating the cryopreservation processes can introduce human error. It is crucial that operators are thoroughly trained in SOPs and deviations are reported immediately.

5. Measurement

Inaccurate or uncalibrated measurement tools (e.g., thermometers, timers) can lead to incorrect temperature assessments and time management during the cryopreservation process. Consistent monitoring and validation of measurement tools is necessary.

6. Environment

The physical environment surrounding cryopreservation operations, including temperature fluctuations and contamination risks, must be closely managed. Adherence to cleanroom standards and monitoring of ambient conditions will help prevent these issues.

Immediate Containment Actions (First 60 Minutes)

Prompt actions taken within the first hour of detecting a cryopreservation failure are crucial in minimizing risks to patient safety and product integrity. Follow these steps:

  1. Immediately quarantine the affected batch or product to prevent its use.
  2. Initiate a review of equipment logs to ascertain if any malfunctions occurred during the cryopreservation window.
  3. Conduct preliminary temperature checks of storage units to evaluate potential deviations.
  4. Notify relevant stakeholders, including QA, Regulatory Affairs, and management, to escalate the issue appropriately.

Documentation of each action taken during this period should be meticulous. This will serve as essential evidence during the root cause investigation.

Investigation Workflow (Data to Collect + How to Interpret)

To conduct an effective investigation of the cryopreservation failure, a structured workflow is essential:

  1. Collect Data: Gather all pertinent records and logs, including batch production records, storage temperature logs, operator training records, and QC testing results. Ensure chain of custody is maintained for all materials.
  2. Step 1: Initial Assessment: Review and evaluate patterns or correlating data that coincide with the failure. Look for deviations in processes or environmental conditions during the affected time frame.
  3. Step 2: Correlation Analysis: Use statistical tools and trending analysis (e.g., Statistical Process Control – SPC) to identify any anomalies in the data.
  4. Step 3: Investigative Team Consolidation: Create a cross-functional investigative team to leverage expertise in critical areas such as manufacturing, quality control, and engineering.

The interpretation of data should be guided by GMP expectations and the principle of ready access to evidence in addressing root causes. Make sure that all discussions and analyses are documented clearly.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

Utilizing the right root cause analysis tools can yield a clear understanding of what went wrong. Here are three effective methodologies:

1. 5-Why Analysis

This iterative technique involves asking “why” multiple times (typically five) to drill down to the core cause of a failure. It is most effective for straightforward problems with clear causative links.

2. Fishbone Diagram (Ishikawa)

This tool groups potential causes into categories (Man, Machine, Method, Material, Measurement, Environment) and visually represents them, allowing for a comprehensive view of possible issues. It is particularly useful for complex problems with multiple interrelated causes.

Related Reads

3. Fault Tree Analysis (FTA)

This deductive structure starts with a specific problem (e.g., cryopreservation failure) and works backward through logical branches to identify all contributing factors. This method is beneficial for more technical problems or those involving intricate systems.

Choose the appropriate tool based on the complexity and context of the failure; integrating multiple tools can also enhance your analysis.

CAPA Strategy (Correction, Corrective Action, Preventive Action)

Creating a robust CAPA strategy post-investigation is crucial for addressing the observed failures and preventing recurrence. Break this strategy down into three components:

1. Correction

This entails immediate actions taken to rectify the detected issue, such as recalling affected products and addressing equipment malfunctions or retraining personnel involved in the process.

2. Corrective Action

Analysing underlying causes, corrective actions could include revising protocols, enhancing equipment calibration procedures, or optimizing the cryopreservation methodology based on findings. Detailed procedures must be documented for training and audit purposes.

3. Preventive Action

Preventive actions focus on minimizing the likelihood of future occurrences. This could involve instituting stricter procedural compliance checks or implementing new monitoring technologies. Evaluate risk management strategies to ensure they are actionable and effectively address known weak points.

Control Strategy & Monitoring (SPC/Trending, Sampling, Alarms, Verification)

Ensuring robust control strategies post-investigation is paramount. These controls should be established and regularly reassessed:

  • Statistical Process Control (SPC): Utilize SPC tools to create control charts, allowing for real-time monitoring of process variations. Ensure that every critical parameter (e.g., temperature during cryopreservation) is continually tracked.
  • Sampling Methods: Implement regular sampling for product viability testing immediately post-thaw. Create a sampling plan that aligns with regulatory expectations and product specifications.
  • Alarm Systems: Ensure equipment has reliable alarm systems for any temperature deviations. Consider incorporating alarm notifications directly to a monitoring team.
  • Verification Processes: Verification of both equipment and processes should be periodically tested to ensure alignment with fixed controls. This includes regular calibration of temperature and data-logging systems.

Validation / Re-qualification / Change Control Impact (When Needed)

In the aftermath of a cryopreservation failure investigation, determining the need for re-validation or change control is critical:

  • Evaluate whether the deviations necessitate re-validating equipment or processes.
    Any modifications to protocols or equipment resulting from CAPA activities may require formal change control processes.
  • Always review historical validation data in conjunction with any changes made. Conduct prospective or retrospective validation studies based on the nature of the changes.

Inspection Readiness: What Evidence to Show (Records, Logs, Batch Docs, Deviations)

Ensuring inspection readiness following a cryopreservation failure investigation involves maintaining comprehensive documentation:

  • Incident Records: Maintain detailed incident reports outlining the findings from the investigation process.
  • Logs and Reports: Ensure logs related to temperature, equipment maintenance, and personnel training are clear and organized.
  • Batch Documentation: Have complete batch records readily accessible, including all QC results and any deviations noted.

These documents will substantiate your response to regulatory audits by demonstrating compliance with Good Manufacturing Practices (GMP) and showing that corrective actions are effectively being implemented.

FAQs

What is cryopreservation failure?

Cryopreservation failure refers to the inability to preserve biological materials, such as cells or tissues, at ultra-low temperatures, which can lead to decreased viability upon thawing.

How can I identify symptoms of cryopreservation failure?

Symptoms typically include OOS results for cell viability, changes in cell morphology or functionality post-thaw, and irregular temperature data from storage devices.

What should be the first step in containment actions?

The immediate action should be to quarantine the affected batch to prevent further use and facilitate investigation.

What is the role of statistical analysis in cryopreservation investigations?

Statistical analysis helps identify trends and correlations in data, allowing for more effective diagnosis of the problem and determining whether deviations are significant.

Which root cause analysis tool is best for our situation?

The choice of root cause tool depends on the complexity of the issue. For simple issues, the 5-Why method works well; for more complex problems, consider using a Fishbone diagram.

What documentation is necessary for a CAPA strategy?

Documentation should include records of corrective and preventive actions taken, data supporting the need for those actions, and any changes in protocols or processes.

When is re-validation or change control needed?

Re-validation or change control processes are needed when significant changes are made to processes or equipment as a result of failure investigations.

How can we ensure inspection readiness?

Maintain thorough documentation of all processes, records of investigations, corrective actions, and evidence of compliance with GMP regulations to ensure you are inspection-ready.

Pharma Tip:  Cell viability failure during stability testing: patient safety impact and disposition